This study included 3602 patients from the International BRCA1/2 Carrier Cohort Study (IBCSS) and explored the relationship between radiation therapy for primary BC and the risk of developing contralateral BC in gBRCA1/2m patients. This evidence concerns the gene BRCA1 and breast cancer.